Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Items 201–235 of 235
Home Intravenous Antibiotic Therapy Programme, 1999
Steinmetz, D., Berkovits, E., Edelstein, H., FLATAU, E., Almany, A., & Raz, R. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0824 · Cited by 15
Cystic fibrosis, intravenous antibiotics, and home therapy
Hammond, L. J., Caldwell, S., & Campbell, P. W. (1991) · Journal of Pediatric Health Care · doi:10.1016/0891-5245(91)90044-q · Cited by 15
Prevention and management of central venous catheter thrombosis
Cobos, E., Dixon, S., & Keung, Y. (1998) · Current Opinion in Hematology · doi:10.1097/00062752-199809000-00009 · Cited by 15
QUALITY ASSURANCE AND OUTCOMES IN OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY
Kunkel, M. J. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70035-0 · Cited by 15
Self-citationHeley, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92920-0 · Cited by 13
Esposito, S. (2000) · Chemotherapy · doi:10.1159/000048566 · Cited by 13
Continuation of Antibiotic Therapy for Serious Bacterial Infections Outside of the Hospital
Gutierrez, K. M. (1996) · Pediatric Annals · doi:10.3928/0090-4481-19961101-10 · Cited by 12
PRACTICE GUIDELINES FOR COMMUNITY-BASED PARENTERAL ANTI-INFECTIVE THERAPY
Williams, D. N., & Raymond, J. L. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70034-9 · Cited by 12
Self-citationHome Intravenous Antibiotic Therapy: Practical Aspects in Children
Leaver, J., Radivan, F., Patel, L., & David, T. J. (1997) · Journal of the Royal Society of Medicine · doi:10.1177/014107689709031s06 · Cited by 11
Nowobilski-Vasilios, A., & Poole, S. K. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.1.76 · Cited by 11
OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY FOR FEVER AND NEUTROPENIA
Tice, A. D. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70031-3 · Cited by 11
Self-citationWood, G., Whitby, M., Hogan, P. G., & Frazer, I. H. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91167-7 · Cited by 11
Practical Guidelines for Developing an Office-Based Program for Outpatient Intravenous Therapy
Green, S. L. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s189 · Cited by 11
Taber, D. J., Fann, A. L., Malat, G., & Dupuis, R. E. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200302000-00010 · Cited by 11
Reducing home nursing visit costs using a remote access infusion pump system.
Chung, M. H., & Akahoshi, M. (1999) · PubMed · Cited by 10
Nathwani, D., Seaton, A., & Davey, P. G. (1997) · Reviews in Medical Microbiology · doi:10.1097/00013542-199707000-00003 · Cited by 10
Radiological Case of the Month
Porea, T. J., Margolin, J., & Chintagumpala, M. (2001) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.155.8.963 · Cited by 10
Outpatient management of the febrile neutropenic child with cancer.
Patrick, C. C., & Shenep, J. L. (1999) · PubMed · Cited by 10
Venous thrombosis of the upper extremities
Lee, A. Y. Y., & Ginsberg, J. S. (2001) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-001-0039-0 · Cited by 9
Home management of antibiotic therapy.
Poretz, D. M. (1989) · PubMed · Cited by 9
Pneumonia and Chronic Lung Disease
Trowbridge, J. F. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442942 · Cited by 9
Home treatment of pulmonary infection in cystic fibrosis
Kuzemko, J. A. (1988) · CHEST Journal · doi:10.1378/chest.94.2.162s · Cited by 9
Adverse Effects of the Use of Intravenous Pentamidine in the Home
Gross, R., Graziani, A. L., Laufer, D. M., Turner, J. L., Ondercin, J. P., & MacGregor, R. R. (1996) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199609000-00015 · Cited by 8
Gentry, L. O., & Khoshdel, A. (1989) · Europe PMC (PubMed Central) · Cited by 6
Parenteral Antibiotic Therapy in Outpatients: Quality Assurance and Other Issues in a Protohospital
Eron, L. J. (2009) · Chemotherapy · doi:10.1159/000238914 · Cited by 6
Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
Ha, N., & Markowitz, A. (1987) · PubMed · Cited by 6
Initiation of Antimicrobial Therapy in the Home
McNulty, T. J. (1993) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/50.4.773 · Cited by 6
TREATMENT OF BACTERIAL MENINGITIS
Alexander, H. E. (1944) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-194406000-00023 · Cited by 5
(1993) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/50.8.1724 · Cited by 5
Sentinel events in home care and hospice organizations
Popovich, M. L. (2000) · Home Care Provider · doi:10.1016/s1084-628x(00)90062-5 · Cited by 4
Antibiotic Administration Options
Bakken, J., Conlon, C. P., Smerud, K. T., Vinen, J., & Wijlhuizen, T. G. (1996) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199601000-00016 · Cited by 4
Bloodborne Pathogen Exposure and Recommendations for Management
Tice, A. D. (2002) · Journal of Infusion Nursing · doi:10.1097/00129804-200211001-00002 · Cited by 4
Self-citationEmergency Department and Urgent Care Center
Lindbeck, G. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442947 · Cited by 4
(2019) · ASHP eBooks · doi:10.37573/9781585286560.018 · Cited by 4
Skokal, W. (2000) · PubMed · Cited by 2
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., & Wilson, W. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,266
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Self-citation
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.